Andujar, Relaine C.
HRN: 23-63-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2023
CEFUROXIME 1.5GM (VIAL)
10/14/2023
10/16/2023
IV
1.5
Q8
CS With BTL
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes